(Q61624883)
Statements
A phase II trial with trastuzumab and pertuzumab in patients with HER2-overexpressed locally advanced and metastatic breast cancer (English)
Neelima Denduluri
Janice M Walshe
Arlene W Berman
Douglas R Rosing
Breast cancer trial article